KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 188 filers reported holding KRYSTAL BIOTECH INC in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,400 | -32.1% | 4,400 | -31.2% | 0.00% | 0.0% |
| Q2 2023 | $751,360 | +23.5% | 6,400 | -15.8% | 0.00% | 0.0% |
| Q1 2023 | $608,456 | -38.1% | 7,600 | -38.7% | 0.00% | -50.0% |
| Q4 2022 | $982,328 | +13.3% | 12,400 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $867,000 | -77.1% | 12,450 | -78.4% | 0.00% | -50.0% |
| Q2 2022 | $3,787,000 | +90.5% | 57,689 | +93.1% | 0.00% | +300.0% |
| Q1 2022 | $1,988,000 | +34.2% | 29,880 | +41.2% | 0.00% | 0.0% |
| Q4 2021 | $1,481,000 | +177.3% | 21,159 | +169.2% | 0.00% | – |
| Q2 2021 | $534,000 | -11.7% | 7,859 | +0.1% | 0.00% | -100.0% |
| Q1 2021 | $605,000 | +26.6% | 7,853 | -1.3% | 0.00% | – |
| Q4 2020 | $478,000 | +39.0% | 7,959 | -0.6% | 0.00% | – |
| Q3 2020 | $344,000 | -4.7% | 8,006 | -8.0% | 0.00% | – |
| Q2 2020 | $361,000 | -61.5% | 8,705 | -59.8% | 0.00% | -100.0% |
| Q1 2020 | $937,000 | -45.8% | 21,652 | -30.7% | 0.00% | -50.0% |
| Q4 2019 | $1,730,000 | +94.2% | 31,235 | +22.6% | 0.00% | +100.0% |
| Q3 2019 | $891,000 | -12.9% | 25,476 | +0.4% | 0.00% | 0.0% |
| Q2 2019 | $1,023,000 | -11.8% | 25,381 | -28.0% | 0.00% | 0.0% |
| Q1 2019 | $1,160,000 | – | 35,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,896,645 | $150,252,217 | 6.15% |
| S Squared Technology, LLC | 108,215 | $8,572,792 | 5.80% |
| Frazier Life Sciences Management, L.P. | 999,737 | $79,199,165 | 4.92% |
| First Light Asset Management, LLC | 473,691 | $37,525,801 | 3.48% |
| Ikarian Capital, LLC | 165,900 | $13,142,598 | 3.17% |
| Soleus Capital Management, L.P. | 188,217 | $14,910,551 | 2.14% |
| Integral Health Asset Management, LLC | 115,000 | $9,110,300 | 1.91% |
| Nicholas Investment Partners, LP | 267,089 | $21,158,791 | 1.85% |
| Artal Group S.A. | 400,000 | $31,688 | 1.77% |
| Avoro Capital Advisors LLC | 1,410,000 | $111,700,200 | 1.67% |